PPD's Lee Babiss On Virtual R&D In China: An Interview With PharmAsia News (Part 1 Of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Babiss speaks of the evolving relationships between pharmaceutical firms and CROs, including end-to-end virtualization of R&D.
You may also be interested in...
German Biotech MAB Discovery Inks Two Deals For Its Rabbit-Derived Antibody Technology
German antibody services company MAB Discovery – forged by former Roche employees – has had its rabbit antibody-derived technology validated by two collaborative agreements with pharma and biotech companies.
PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter
BEIJING - As part of a rapid-fire expansion across Asia, the U.S.-headquartered PPD has outlined plans to purchase and merge with the Beijing-based contract research organization BioDuro
Quintiles And Eisai Collaborate To Develop Cancer Compounds
Moving beyond the traditional contract research organization model, Quintiles will collaborate with Eisai to perform 11 proof-of-concept trials on six oncology compounds in a deal announced Oct. 30